Artivion Reports Q1 2026 Earnings with Revenue Growth

Artivion (AORT) reported first-quarter earnings for 2026 on May 7, showing a revenue increase of $116.3 million and adjusted EBITDA growth to $22.1 million. The company noted strong performance in tissue processing and On-X stent grafts but faced challenges with BioGlue sales and international market underperformance.

By Motley Fool Transcribing · Motley Fool ·

Artivion Reports Q1 2026 Earnings with Revenue Growth

Tickers: $AORT

Topics: adjusted EBITDA growth market performance revenue

Read the full article at Motley Fool

More World news